Response to hepatitis A vaccine in HIV patients in the HAART era.
We evaluated the development of hepatitis A antibody after vaccination in a large cohort of patients studied in a clinical setting after the introduction of HAART. Overall, 130 of 214 vaccinated individuals developed hepatitis A antibody. In a multivariate analysis, only the CD4 cell count at the time of vaccination was associated with an absence of response. The lack of association with the nadir CD4 cell count suggests that patients will respond to vaccine after immunological reconstitution in response to HAART.
Rimland
David
D
VA Medical Center and Emory University School of Medicine, Atlanta, GA, USA.
Guest
Jodie L
JL
D023241:Antiretroviral Therapy, Highly Active; D018791:CD4 Lymphocyte Count; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology; D035922:Hepatitis A Antibodies / Q000096:biosynthesis*; D022362:Hepatitis A Vaccines / Q000276:immunology*; D006801:Humans; D011446:Prospective Studies
D035922:Hepatitis A Antibodies; D022362:Hepatitis A Vaccines